Category

GVHD

Kalytera Completes Pre-IND Meeting with FDA

By | GVHD, Press Release
Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it met with the United States Food & Drug Administration (“FDA”) for a pre-Investigational New Drug (“pre-IND”) meeting regarding the Company’s program evaluating cannabidiol...
Read More